Abiraterone acetate is a steroidal CYP17A1 inhibitor and by extension androgen synthesis inhibitor which is used in combination with prednisone in metastatic castration-resistant prostate cancer.
Website Designed By : WebProfits
Premium Member Of : Dial4Trade